Moneycontrol PRO
UPCOMING EVENT:Are you 45+? Planning for retirement? We have just the right webinar for you - Planning for Retirement with Life Insurance on 27-Jan, 3pm. Register now!

Unichem Laboratories share gains 7% on USFDA nod to Aripiprazole tablets

The share touched a 52-week high of Rs 374.90 and a 52-week low of Rs 197.50 on May 21, 2021 and November 22, 2021, respectively

December 03, 2021 / 09:41 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Unichem Laboratories share price rose over 7 percent in the early trading hours on December 3 after its schizophrenia pill received approval from the US Food and Drug Administration (USFDA).


Unichem Laboratories has received ANDA approval for its Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg from the United States Food and Drug Administration to market a generic version of Abilify Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, of Otsuka Pharmaceutical Company Ltd,” the company said in a statement.


Aripiraprazole tablets are indicated for schizophrenia and irritability associated with autistic disorders. The product will be commercialised from Unichem’s Ghaziabad plant.


At 9:22am, Unichem Laboratories was quoting at Rs 234.45, up Rs 11.20, or 5.02 percent, on the BSE.


Catch all the market action on our live blog

Close

The share touched a 52-week high of Rs 374.90 and a 52-week low of Rs 197.50 on May 21, 2021 and November 22, 2021, respectively. It was trading 37.46 percent below its 52-week high and 18.71 percent above its 52-week low on December 3.

Moneycontrol News
first published: Dec 3, 2021 09:41 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark